As of September 2024 Biomark Diagnostics has 82.78M shares outstanding, a increase of 6.22% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 82.78M | 6.22% |
2022 | 77.93M | 6.31% |
2021 | 73.30M | 2.82% |
2020 | 71.30M | - |